Tetragon Partners GP Ltd: UIPATH INC (PATH): Quarterly 13F Position History
As of Q1 2026, Tetragon Partners GP Ltd reported 25,207,628 shares of UIPATH INC (PATH), worth $279.8M and representing 55.0% of its 13F equity book. Quarter-over-quarter share count change: + 7,757,628 (+44.5%) . The position first appeared in Q1 2022 and has been disclosed across 17 13F-HR filings in Pactolio's tracked window.
- 25,207,628Shares Held (Latest Filing)
- $279.8MReported Market Value (Latest Filing)
- 55.0%Portfolio Weight (% of 13F Equity Book)
- +7,757,628Quarter-over-Quarter Share Change
- -$6.2MQuarter-over-Quarter Value Change
- 25,207,628Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 17 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 25,207,628 | +7,757,628 | +44.5% | $279.8M | 55.0% | $11.1 |
| Q4 2025 | 17,450,000 | +500,000 | +2.9% | $286.0M | 60.3% | $16.4 |
| Q3 2025 | 16,950,000 | +3,227,756 | +23.5% | $226.8M | 32.9% | $13.4 |
| Q2 2025 | 13,722,244 | +4,772,244 | +53.3% | $175.6M | 31.7% | $12.8 |
| Q1 2025 | 8,950,000 | +2,000,000 | +28.8% | $92.2M | 29.6% | $10.3 |
| Q4 2024 | 6,950,000 | 0 | — | $88.3M | 27.3% | $12.7 |
| Q3 2024 | 6,950,000 | +950,000 | +15.8% | $89.0M | 28.3% | $12.8 |
| Q2 2024 | 6,000,000 | +3,500,000 | +140.0% | $76.1M | 23.6% | $12.7 |
| Q1 2024 | 2,500,000 | +200,000 | +8.7% | $56.7M | 15.6% | $22.7 |
| Q4 2023 | 2,300,000 | 1,000,000 | -30.3% | $57.1M | 14.5% | $24.8 |
| Q3 2023 | 3,300,000 | 29,110 | -0.9% | $56.5M | 10.3% | $17.1 |
| Q2 2023 | 3,329,110 | +336,410 | +11.2% | $55.2M | 7.4% | $16.6 |
| Q1 2023 | 2,992,700 | +177,170 | +6.3% | $52.6M | 7.0% | $17.6 |
| Q4 2022 | 2,815,530 | +815,530 | +40.8% | $35.8M | 5.1% | $12.7 |
| Q3 2022 | 2,000,000 | +250,000 | +14.3% | $25.2M | 3.0% | $12.6 |
| Q2 2022 | 1,750,000 | +750,000 | +75.0% | $31.8M | 2.2% | $18.2 |
| Q1 2022 | 1,000,000 | — | — | $21.6M | 1.0% | $21.6 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Tetragon Partners GP Ltd first disclose a PATH position in 13F-HR filings?
Tetragon Partners GP Ltd first reported UIPATH INC (PATH) on its 13F-HR filing for the period ending 2022-03-31 (Q1 2022). The position has appeared on 17 reported quarters within Pactolio's tracked window.
What was Tetragon Partners GP Ltd's most recent quarter-over-quarter share-count change in PATH?
Between Q4 2025 and Q1 2026, Tetragon Partners GP Ltd added 7,757,628 shares of PATH (+44.5%), bringing the total reported position to 25,207,628 shares at a market value of $279.8M.
Does the implied price-per-share represent Tetragon Partners GP Ltd's cost basis in PATH?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.